Medicine

D. Urut, Derya Karabulut, Savaş Hereklioğlu, Gülşah Özdemir, Berkin Anıl Cicin, B. Hacıoglu, Necet Süt, N. Tunçbilek

2024.1.26Radiologie

DOI: 10.1007/s00117-023-01254-0

tlooto Summary

It is believed that DTI measurements can be used as a biomarker for OS analysis in breast cancer given the available data and the first study to assess the prognostic value of DTI–MRI in breast cancer with statistical survival analysis techniques.

Abstract

Abstract is not available.

Citation format

URUT, D., et al. Diffusion tensor imaging: Survival analysis prediction in breast cancer patients. Radiologie, 2024, 64: 54–59.